Cargando…
Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638987/ https://www.ncbi.nlm.nih.gov/pubmed/34855763 http://dx.doi.org/10.1371/journal.pntd.0009375 |
_version_ | 1784609056678215680 |
---|---|
author | Nigo, Maurice M. Odermatt, Peter Nigo, David Wully Salieb-Beugelaar, Georgette B. Battegay, Manuel Hunziker, Patrick R. |
author_facet | Nigo, Maurice M. Odermatt, Peter Nigo, David Wully Salieb-Beugelaar, Georgette B. Battegay, Manuel Hunziker, Patrick R. |
author_sort | Nigo, Maurice M. |
collection | PubMed |
description | BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidity associated with Schistosoma mansoni infection. For this reason, we aimed to assess intestinal and hepatosplenic morbidity associated with S. mansoni infection in Ituri Province. METHODS/PRINCIPAL FINDINGS: In 2017, we conducted a cross-sectional study in 13 villages in Ituri Province, DRC. S. mansoni infection was assessed with a Kato-Katz stool test (2 smears) and a point-of-care circulating cathodic antigen (POC-CCA) urine test. A questionnaire was used to obtain demographic data and information about experienced intestinal morbidity. Each participant underwent an abdominal ultrasonography examination to diagnose hepatosplenic morbidity. Of the 586 study participants, 76.6% tested positive for S. mansoni. Intestinal morbidity reported in the two preceding weeks was very frequent, and included abdominal pain (52.7%), diarrhoea (23.4%) and blood in the stool (21.5%). Hepatosplenic morbidity consisted of abnormal liver parenchyma patterns (42.8%), hepatomegaly (26.5%) and splenomegaly (25.3%). Liver pathology (adjusted odds ratio [aOR] 1.20, 95% confidence interval [CI] 1.06–1.37, p = 0.005) was positively and significantly associated with S. mansoni infection. Hepatomegaly (aOR 1.52, 95% CI 0.99–2.32, p = 0.053) and splenomegaly (aOR 1.12, 95% CI 0.73–1.72, p = 0.619) were positively but not significantly associated with S. mansoni infection at the individual level. At the village level, S. mansoni prevalence was positively associated with the prevalence of hepatomegaly and splenomegaly. High-intensity S. mansoni infections were associated with diarrhoea, blood in the stool, hepatomegaly, splenomegaly, and liver parenchyma (C, D, E and F pathology patterns). Four study participants were diagnosed with ascites and five reported hematemesis. CONCLUSIONS/SIGNIFICANCE: Our study documents a high burden of intestinal and hepatosplenic morbidity associated with S. mansoni infection status in Ituri Province. The findings call for targeted interventions to address both S. mansoni infection and related morbidity. |
format | Online Article Text |
id | pubmed-8638987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-86389872021-12-03 Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo Nigo, Maurice M. Odermatt, Peter Nigo, David Wully Salieb-Beugelaar, Georgette B. Battegay, Manuel Hunziker, Patrick R. PLoS Negl Trop Dis Research Article BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidity associated with Schistosoma mansoni infection. For this reason, we aimed to assess intestinal and hepatosplenic morbidity associated with S. mansoni infection in Ituri Province. METHODS/PRINCIPAL FINDINGS: In 2017, we conducted a cross-sectional study in 13 villages in Ituri Province, DRC. S. mansoni infection was assessed with a Kato-Katz stool test (2 smears) and a point-of-care circulating cathodic antigen (POC-CCA) urine test. A questionnaire was used to obtain demographic data and information about experienced intestinal morbidity. Each participant underwent an abdominal ultrasonography examination to diagnose hepatosplenic morbidity. Of the 586 study participants, 76.6% tested positive for S. mansoni. Intestinal morbidity reported in the two preceding weeks was very frequent, and included abdominal pain (52.7%), diarrhoea (23.4%) and blood in the stool (21.5%). Hepatosplenic morbidity consisted of abnormal liver parenchyma patterns (42.8%), hepatomegaly (26.5%) and splenomegaly (25.3%). Liver pathology (adjusted odds ratio [aOR] 1.20, 95% confidence interval [CI] 1.06–1.37, p = 0.005) was positively and significantly associated with S. mansoni infection. Hepatomegaly (aOR 1.52, 95% CI 0.99–2.32, p = 0.053) and splenomegaly (aOR 1.12, 95% CI 0.73–1.72, p = 0.619) were positively but not significantly associated with S. mansoni infection at the individual level. At the village level, S. mansoni prevalence was positively associated with the prevalence of hepatomegaly and splenomegaly. High-intensity S. mansoni infections were associated with diarrhoea, blood in the stool, hepatomegaly, splenomegaly, and liver parenchyma (C, D, E and F pathology patterns). Four study participants were diagnosed with ascites and five reported hematemesis. CONCLUSIONS/SIGNIFICANCE: Our study documents a high burden of intestinal and hepatosplenic morbidity associated with S. mansoni infection status in Ituri Province. The findings call for targeted interventions to address both S. mansoni infection and related morbidity. Public Library of Science 2021-12-02 /pmc/articles/PMC8638987/ /pubmed/34855763 http://dx.doi.org/10.1371/journal.pntd.0009375 Text en © 2021 Nigo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Nigo, Maurice M. Odermatt, Peter Nigo, David Wully Salieb-Beugelaar, Georgette B. Battegay, Manuel Hunziker, Patrick R. Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title | Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title_full | Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title_fullStr | Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title_full_unstemmed | Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title_short | Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo |
title_sort | morbidity associated with schistosoma mansoni infection in north-eastern democratic republic of the congo |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638987/ https://www.ncbi.nlm.nih.gov/pubmed/34855763 http://dx.doi.org/10.1371/journal.pntd.0009375 |
work_keys_str_mv | AT nigomauricem morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo AT odermattpeter morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo AT nigodavidwully morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo AT saliebbeugelaargeorgetteb morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo AT battegaymanuel morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo AT hunzikerpatrickr morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo |